Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases Thumbnail Image Read more about Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases
FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma Thumbnail Image Read more about FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma
FDA Approves Targeted Treatment for Rare, Aggressive form of Blood Cancer Thumbnail Image Read more about FDA Approves Targeted Treatment for Rare, Aggressive form of Blood Cancer
FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease Thumbnail Image Read more about FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease
Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma Thumbnail Image Read more about Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma
FDA Approves Immunotherapy for Aggressive Form of Follicular Lymphoma Thumbnail Image Read more about FDA Approves Immunotherapy for Aggressive Form of Follicular Lymphoma
FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid Leukemia Thumbnail Image Read more about FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid Leukemia
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis) Thumbnail Image Read more about FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
FDA Approves New Treatment Option for Patients with Multiple Myeloma at First or Subsequent Relapse Thumbnail Image Read more about FDA Approves New Treatment Option for Patients with Multiple Myeloma at First or Subsequent Relapse
FDA Approves the First Interferon for Adults With Polycythemia Vera Thumbnail Image Read more about FDA Approves the First Interferon for Adults With Polycythemia Vera
